SCHEMBL20127693

SCHEMBL20127693

c1cc(-c2c3ccccc3c(-c3cc4c5ccccc5oc4c4c3oc3ccccc34)c3ccccc23)cc(-c2cc3ccccc3c3ccccc23)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 3/20 0.37
CYP11B1 P15538 1/20 0.35
KDM4E B2RXH2 6/20 0.33
ALDH1A1 P00352 5/20 0.33
HPGD P15428 4/20 0.33
HSD17B10 Q99714 4/20 0.33
MAPT P10636 4/20 0.33
TSHR P16473 3/20 0.33
CASP1 P29466 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
RAB9A P51151 2/20 0.33
CASP7 P55210 2/20 0.33
MAPK1 P28482 2/20 0.33
AHR P35869 1/20 0.33
HIF1A Q16665 1/20 0.33
CDC14B O60729 1/20 0.33
CDC14A Q9UNH5 1/20 0.33
MAOB P27338 1/20 0.33
ALOX15 P16050 1/20 0.33
GGPS1 O95749 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10122306 0.95 ALOX5 (0.37) ALOX5CYP11B1KDM4EALDH1A1HPGD
SCHEMBL19294639 0.90 ALOX5 (0.36) ALOX5CYP11B1KDM4EALDH1A1HPGD
SCHEMBL10122233 0.89 ALOX5 (0.40) ALOX5KDM4EALDH1A1HPGDHSD17B10
SCHEMBL20127425 0.89 ALOX5 (0.42) ALOX5CYP11B1KDM4EALDH1A1HPGD
SCHEMBL10122477 0.89 ALOX5 (0.42) ALOX5CYP11B1KDM4EALDH1A1HPGD
SCHEMBL10122238 0.89 AHR (0.39) ALOX5CYP11B1KDM4EALDH1A1HPGD
SCHEMBL10122236 0.87 PLA2G2A (0.40) ALOX5KDM4EALDH1A1HPGDHSD17B10
SCHEMBL23094345 0.87 PLA2G2A (0.35) ALOX5KDM4EALDH1A1HPGDHSD17B10
SCHEMBL10122305 0.87 ALOX5 (0.40) ALOX5KDM4EALDH1A1HPGDHSD17B10
SCHEMBL20127700 0.86 ALOX5 (0.51) ALOX5KDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 ALOX5 4115/4885CYP11B1 483/4885KDM4E 4144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.